DEMAREE JOHN 4
4 · G1 Therapeutics, Inc. · Filed Jul 6, 2018
Insider Transaction Report
Form 4
DEMAREE JOHN
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2018-07-03+225,000→ 225,000 totalExercise: $45.50Exp: 2028-07-03→ Common Stock (225,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest as to 25% of the shares on July 3, 2019, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.